These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 29771752)
21. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy. Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of combined immunosuppression and orbital radiotherapy in thyroid-related restrictive myopathy: two-center experience. Chalvatzis NT; Tzamalis AK; Kalantzis GK; El-Hindy N; Dimitrakos SA; Potts MJ Eur J Ophthalmol; 2014; 24(6):953-9. PubMed ID: 24706350 [TBL] [Abstract][Full Text] [Related]
23. The eye and thyroid disease. Kuriyan AE; Phipps RP; Feldon SE Curr Opin Ophthalmol; 2008 Nov; 19(6):499-506. PubMed ID: 18854695 [TBL] [Abstract][Full Text] [Related]
24. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences]. Juri J; Stiglmayer N; Kuzman T Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease. Strianese D Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S56-S59. PubMed ID: 29923966 [TBL] [Abstract][Full Text] [Related]
26. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study. Ng CM; Yuen HK; Choi KL; Chan MK; Yuen KT; Ng YW; Tiu SC Hong Kong Med J; 2005 Oct; 11(5):322-30. PubMed ID: 16219950 [TBL] [Abstract][Full Text] [Related]
27. Acute dysthyroid optic neuropathy exacerbated by orbital radiotherapy. Hersh D; Kinnar M Orbit; 2014 Oct; 33(5):385-7. PubMed ID: 24841498 [TBL] [Abstract][Full Text] [Related]
28. Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease. Strianese D Curr Opin Ophthalmol; 2017 Sep; 28(5):505-513. PubMed ID: 28700384 [TBL] [Abstract][Full Text] [Related]
29. [Radiation therapy for thyroid-associated ophthalmopathy]. Luo QL; He WM; Tang L; Chen LJ Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):218-21. PubMed ID: 16643752 [TBL] [Abstract][Full Text] [Related]
30. Treatment of mild, moderate-to-severe and very severe Graves' orbitopathy. Marcocci C; Marinò M Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):325-37. PubMed ID: 22632369 [TBL] [Abstract][Full Text] [Related]
31. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
32. Advances in the management of thyroid eye diseases: An overview. Kumari R; Chandra Saha B Int Ophthalmol; 2018 Oct; 38(5):2247-2255. PubMed ID: 28822031 [TBL] [Abstract][Full Text] [Related]